TMCnet News
BenevolentAI to Present at 41st Annual J.P. Morgan Healthcare ConferenceBenevolentAI ??(Euronext Amsterdam: BAI), a leading clinical-stage AI drug discovery company, announces that it will participate in the upcoming 41st Annual J.P. Morgan Healthcare Conference in San Francisco, US from 9-12 January 2023. Joanna Shields, Chief Executive Officer of BenevolentAI is scheduled to present at 14:15 PST (22:15 GMT) on Monday, 9 January 2023. The webcast link and slides will be made available on BenevolentAI's Investor Relations portal. BenevolentAI's management, investor relations and business development teams will be attending and available throughout the conference for meetings.
About BenevolentAI
View source version on businesswire.com: https://www.businesswire.com/news/home/20221130006148/en/ |